{Reference Type}: Journal Article
{Title}: Advances in meniscus tissue engineering: Towards bridging the gaps from bench to bedside.
{Author}: Bian Y;Cai X;Zhou R;Lv Z;Xu Y;Wang Y;Wang H;Zhu W;Sun H;Zhao X;Feng B;Weng X;
{Journal}: Biomaterials
{Volume}: 312
{Issue}: 0
{Year}: 2025 Jan 27
{Factor}: 15.304
{DOI}: 10.1016/j.biomaterials.2024.122716
{Abstract}: Meniscus is vital for maintaining the anatomical and functional integrity of knee. Injuries to meniscus, commonly caused by trauma or degenerative processes, can result in knee joint dysfunction and secondary osteoarthritis, while current conservative and surgical interventions for meniscus injuries bear suboptimal outcomes. In the past decade, there has been a significant focus on advancing meniscus tissue engineering, encompassing isolated scaffold strategies, biological augmentation, physical stimulus, and meniscus organoids, to improve the prognosis of meniscus injuries. Despite noteworthy promising preclinical results, translational gaps and inconsistencies in the therapeutic efficiency between preclinical and clinical studies exist. This review comprehensively outlines the developments in meniscus tissue engineering over the past decade (Scheme 1). Reasons for the discordant results between preclinical and clinical trials, as well as potential strategies to expedite the translation of bench-to-bedside approaches are analyzed and discussed.